Literature DB >> 174187

Substrate specificity of lecithin:cholesterol acyltransferase. Esterification of desmosterol, b-sitosterol, and cholecalciferol in human plasma.

G Nordby, K R Norum.   

Abstract

Desmosterol and beta-sitosterol were esterified when incubated with normal human plasma. The initial rate of demosterol esterification was 1.7 times faster, and that of beta-sitosterol 0.4 times slower, than the esterification rate of cholesterol. These ratios were found to be almost the same when plasma from different normal individuals was tested. Plasma from a patient with familial lecithin:cholesterol acyltransferase deficiency did not esterify any of the sterols. The esterification of desmosterol and beta-sitosterol was considerably slower in normal plasma in which in vitro cholesterol esterification previously had taken place. The different esterification rates could not be explained by a different affinity of the plasma lipoproteins for the sterols tested. Cholecalciferol added to normal plasma did not become esterified.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 174187

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  4 in total

1.  Inhibition of cholesterol absorption by HMG-CoA reductase inhibitor.

Authors:  T A Miettinen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Utilization of various sterols by lecithin-cholesterol acyltransferase as acyl acceptors.

Authors:  U Piran; T Nishida
Journal:  Lipids       Date:  1979-05       Impact factor: 1.880

3.  Serum cholesterol precursor sterols in coeliac disease: effects of gluten free diet and cholestyramine.

Authors:  M Vuoristo; T A Miettinen
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

4.  Fatty acid composition of individual plasma steryl esters in phytosterolemia and xanthomatosis.

Authors:  A Kuksis; J J Myher; L Marai; J A Little; R G McArthur; D A Roncari
Journal:  Lipids       Date:  1986-06       Impact factor: 1.880

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.